About Enhancer

Enhancer ID: E_02_0842
Species: human
Position : chr12:85515101-85543901
Biosample name:
Experiment class : Low+High throughput
Enhancer type: Enhancer
Disease: --
Pubmed ID:  26663721
Enhancer experiment: ChIP-seq
Enhancer experiment description: To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.

About Target gene

Target gene : Fos-Jdp2?(Jundm2,Jundp2,TIF),Fos-Jdp2?(Jundm2,Jundp2,TIF),Fos-Jdp2?(Jundm2,Jundp2,TIF),Fos-Jdp2?(Jundm2,Jundp2,TIF),Fos-Jdp2?(Jundm2,Jundp2,TIF),Fos-Jdp2?(Jundm2,Jundp2,TIF),Fos-Jdp2?(Jundm2,Jundp2,TIF),Fos-Jdp2?(Jundm2,Jundp2,TIF),Fos-Jdp2?(Jundm2,Jundp2,TIF)
Strong evidence: --
Less strong evidence: ChIP-seq
Target gene experiment description: To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.;To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.;To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.;To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.;To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.;To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.;To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.;To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.;To identify the sites involved in the GC response in the two species,Chromatin immunoprecipitation for GR and sequencing (ChIP-seq) was performed 2 h after dexamethasone treatment in both mBMDM and hMDM. Representative UCSC browser tracks for GR binding in mBMDM and hMDM are shown in Fig. 2A and 2C.ChIP-seq data tracks from the UCSC browser for the Fos Jdp2 region, for GR binding in mBMDM. Data from ChIP with anti-GR antibodies after treatment with 100nM dexamethasone for 2h (Dex GR IP), input material (Dex input) and immunoprecipitated material from a vehicle treated control (Vehicle GR IP) are shown. Enriched motifs found de novo within GR bound sites in mBMDM and hMDM.

About TF

TF name : ------------------
TF experiment: --
TF experiment description: --;--;--;--;--;--;--;--;--

About Function

Enhancer function : --
Enhancer function experiment: --
Enhancer function
experiment description:
--

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs